1. America’s Health Insurance Plans. The rise of orphan drugs. https://www.ahip.org/wp-content/uploads/IB_OrphanDrugs-1004.pdf. Accessed 2 Jul 2021.
2. US Food and Drug Administration. Innovation in new drug approvals of 2019 advances patient care across a broad range of diseases. https://www.fda.gov/news-events/fda-voices/innovation-new-drug-approvals-2019-advances-patient-care-across-broad-range-diseases. Accessed 2 Jul 2021.
3. US Food and Drug Administration. New drug therapy approvals 2020. https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2020. Accessed 2 Jul 2021.
4. EvaluatePharma. Orphan drug report 2019. 6th edition, April 2019. https://info.evaluate.com/rs/607-YGS-364/images/EvaluatePharma%20Orphan%20Drug%20Report%202019.pdf. Accessed 2 Jul 2021.
5. IQVIA Institute for Human Data Science. Orphan drugs in the United States: growth trends in rare disease treatments. October 2018. https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/orphan-drugs-in-the-united-states-growth-trends-in-rare-disease-treatments.pdf. Accessed 2 Jul 2021.